A non-invasive, easy-to-use test, like the Cologuard test, is a simple and effective way to screen for colorectal cancer. In ...

"Mainz Biomed partners with Quest for colorectal cancer screening test" was originally created and published by Medical ...

Colon cancer screening is only effective if you complete the test. With 53,000 Americans expected to die from colon cancer in ...

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has ...

While bowel cancer – or colorectal cancer – has traditionally been more common in people over the age of 50, cases in the ...

Bowel cancer, also known as colorectal cancer, is an aggressive cancer with a high incidence in developed countries.

In preliminary data, the test has demonstrated ‘promising’ specificity and sensitivity in detecting early-stage colorectal cancer and advanced ... the ColoAlert test kit, contingent upon ...

BERKELEY, Calif. and MAINZ, Germany, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the ...

Mainz Biomed’s stool-based ColoAlert test is designed to detect colorectal cancer tumor DNA to aid in ... testing services based on the test kit for an eighteen-month period, assuming its ...